• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒丁岛西北部多发性硬化症的流行病学:与其他意大利人相比,撒丁岛人发病率更高的进一步证据。

Epidemiology of multiple sclerosis in Northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians.

作者信息

Rosati G, Aiello I, Pirastru M I, Mannu L, Sanna G, Sau G F, Sotgiu S

机构信息

Neurological Clinic, University of Sassari, Italy.

出版信息

Neuroepidemiology. 1996 Jan-Feb;15(1):10-9. doi: 10.1159/000109884.

DOI:10.1159/000109884
PMID:8719044
Abstract

The Sardinians are an ethnically homogeneous population, having a genetic structure quite different from that of all other Italian and European populations. All epidemiological studies carried out in Sardinia since 1975 indicate that this Mediterranean island shows twice the prevalence of multiple sclerosis (MS) compared to continental Italy, but the size of the Sardinian communities so far surveyed has been too small to draw definitive conclusions. To overcome this draw-back, we have studied the frequency of MS in a well-defined area of north-western Sardinia, with a population of about 270,000 in the 1991 census. Based on 276 MS cases, the prevalence on December 31st, 1991, was 102.6 per 100,000. The incidence, averaging 2 per 100,000 in the period of 1962 to 1971, rose to 5 in the period from 1977 to 1991. The present study confirms the higher frequency of MS among Sardinians compared to other Italian populations. Genetic, linguistic and historical data suggest a role of environmental and genetic factors in determining the notable difference in MS risk between Sardinia and the rest of Italy.

摘要

撒丁岛人是一个种族同质化的群体,其基因结构与所有其他意大利人和欧洲人群有很大不同。自1975年以来在撒丁岛进行的所有流行病学研究表明,这个地中海岛屿的多发性硬化症(MS)患病率是意大利大陆的两倍,但迄今为止所调查的撒丁岛社区规模过小,无法得出明确结论。为克服这一缺陷,我们研究了撒丁岛西北部一个明确界定区域内的MS发病率,1991年人口普查时该区域人口约为27万。基于276例MS病例,1991年12月31日的患病率为每10万人102.6例。发病率在1962年至1971年期间平均为每10万人2例,在1977年至1991年期间升至每10万人5例。本研究证实,与其他意大利人群相比,撒丁岛人中MS的发病率更高。基因、语言和历史数据表明,环境和遗传因素在决定撒丁岛与意大利其他地区MS风险的显著差异中发挥了作用。

相似文献

1
Epidemiology of multiple sclerosis in Northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians.撒丁岛西北部多发性硬化症的流行病学:与其他意大利人相比,撒丁岛人发病率更高的进一步证据。
Neuroepidemiology. 1996 Jan-Feb;15(1):10-9. doi: 10.1159/000109884.
2
The increasing incidence and prevalence of MS in a Sardinian province.
Neurology. 2000 Sep 26;55(6):842-8. doi: 10.1212/wnl.55.6.842.
3
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk.撒丁岛的多发性硬化症流行病学:风险真正增加的证据。
Acta Neurol Scand. 2001 Jan;103(1):20-6. doi: 10.1034/j.1600-0404.2001.00207.x.
4
Epidemiology of myasthenia gravis in northwestern Sardinia.撒丁岛西北部重症肌无力的流行病学
Neuroepidemiology. 1997;16(4):199-206. doi: 10.1159/000109688.
5
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.撒丁岛人群中北欧来源的多发性硬化症风险等位基因富集现象。
Mult Scler. 2015 Oct;21(11):1396-403. doi: 10.1177/1352458515581872. Epub 2015 Apr 28.
6
Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy.特定人群中的多发性硬化症复杂性:意大利撒丁岛的挑战
Eur J Neurol. 2002 Jul;9(4):329-41. doi: 10.1046/j.1468-1331.2002.00412.x.
7
Epidemiology of multiple sclerosis in south-western Sardinia.撒丁岛西南部多发性硬化症的流行病学研究。
Mult Scler. 2011 Nov;17(11):1282-9. doi: 10.1177/1352458511408754. Epub 2011 Jun 7.
8
Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy.意大利撒丁岛儿科人群中的多发性硬化症流行病学
Eur J Pediatr. 2016 Jan;175(1):19-29. doi: 10.1007/s00431-015-2588-3. Epub 2015 Jul 10.
9
Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey.意大利帕多瓦多发性硬化症发病率上升:一项30年的流行病学调查。
Mult Scler. 2003 Aug;9(4):387-92. doi: 10.1191/1352458503ms920oa.
10
The burden of multiple sclerosis variants in continental Italians and Sardinians.意大利大陆地区居民和撒丁岛居民中多发性硬化症变异的负担。
Mult Scler. 2015 Oct;21(11):1385-95. doi: 10.1177/1352458515596599.

引用本文的文献

1
Synapse Dysfunctions in Multiple Sclerosis.多发性硬化症中的突触功能障碍。
Int J Mol Sci. 2023 Jan 13;24(2):1639. doi: 10.3390/ijms24021639.
2
High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018.挪威默勒-鲁姆斯达尔郡多发性硬化症的发病率和患病率较高,1950-2018 年。
Neurol Neuroimmunol Neuroinflamm. 2020 Mar 26;7(3). doi: 10.1212/NXI.0000000000000713. Print 2020 May.
3
HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family.在一个意大利多代家庭中证实了HLA - DRB1*15与多发性硬化症的关联。
Funct Neurol. 2017 Apr/Jun;32(2):83-88. doi: 10.11138/fneur/2017.32.2.083.
4
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.欧洲多发性硬化症的发病率和患病率:系统评价。
BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128.
5
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.1985-2009 年欧洲经济区人群多发性硬化症发病率:监测框架。
BMC Neurol. 2013 Jun 12;13:58. doi: 10.1186/1471-2377-13-58.
6
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.
7
TCRBV20S1 polymorphism does not influence the susceptibility to type 1 diabetes and multiple sclerosis in the Sardinian population.TCRBV20S1 多态性不会影响撒丁岛人群中 1 型糖尿病和多发性硬化症的易感性。
Immunogenetics. 2012 Feb;64(2):153-4. doi: 10.1007/s00251-011-0575-z. Epub 2011 Sep 17.
8
Temporal trends in the incidence of multiple sclerosis: a systematic review.多发性硬化症发病率的时间趋势:一项系统综述。
Neurology. 2008 Jul 8;71(2):129-35. doi: 10.1212/01.wnl.0000316802.35974.34.
9
Multiple sclerosis in the province of Ferrara : evidence for an increasing trend.费拉拉省的多发性硬化症:呈现上升趋势的证据。
J Neurol. 2007 Dec;254(12):1642-8. doi: 10.1007/s00415-007-0560-5. Epub 2007 Nov 16.
10
Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents.意大利引入新型疾病修正药物后复发缓解型多发性硬化症的成本分析。
Clin Drug Investig. 2004;24(7):409-20. doi: 10.2165/00044011-200424070-00004.